Literature DB >> 20857338

Night-to-night repeatability of measurements of nocturnal breathing disorders in clinically stable chronic heart failure patients.

Roberto Maestri1, Maria Teresa La Rovere, Elena Robbi, Gian Domenico Pinna.   

Abstract

BACKGROUND: Portable sleep apnea monitors are often used to screen for sleep-disordered breathing in chronic heart failure patients (CHF), but night-to-night repeatability of obtained measurements of nocturnal breathing disorders has not been fully assessed.
METHODS: Fifty-six stable, moderate-to-severe CHF patients [male, 87%; age, 57 ± 9 years; NYHA class, 2.6 ± 0.6; left ventricular ejection fraction (LVEF), 32% ± 9%] underwent an unattended in-hospital cardiorespiratory recording using a portable sleep apnea monitor during two consecutive nights. The apnea/hypopnea index (AHI), apnea index (AI), oxygen desaturation index (ODI), and periodic breathing (PB) duration were computed. Intra-subject night-to-night variability was assessed by the 95% limits of random variation (LoV). We also estimated the contribution of intra-rater variability to the overall intra-subject variability. Dichotomizing the AHI and PB duration according to conventional cutoffs of, respectively, ≥5 events per hour, ≥15 events per hour, and ≥120 min, the percentage of patients concordantly classified by the two measurements was finally computed.
RESULTS: The 95% LoV were ±10.6, ±7.7, ±11.3 events per hour for AHI, AI and ODI, and ±63.2 min for PB duration, respectively. The contribution of intra-rater variability to total intra-subject variability was 1.7%, 1.4%, 2.5%, and 1.3% for AHI, AI, ODI, and PB duration, respectively. Most patients (85%, 82%, and 95% for AHI ≥ 5, AHI ≥ 15, and PB duration, respectively) were classified concordantly by the two measurements.
CONCLUSIONS: In patients with heart failure, measurements of severity of sleep-disordered breathing derived from portable sleep apnea monitors show significant night-to-night intra-subject variation with a negligible contribution from intra-rater variability; however, using the same measurements for classification purposes, as commonly performed in clinical practice to screen patients for sleep-disordered breathing, very stable results are obtained.

Entities:  

Mesh:

Year:  2010        PMID: 20857338     DOI: 10.1007/s11325-010-0418-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  15 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

Review 2.  Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy.

Authors:  Jean-Louis Pépin; Nathalie Chouri-Pontarollo; Renaud Tamisier; Patrick Lévy
Journal:  Sleep Med Rev       Date:  2005-12-22       Impact factor: 11.609

Review 3.  Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine.

Authors:  G Atkinson; A M Nevill
Journal:  Sports Med       Date:  1998-10       Impact factor: 11.136

4.  Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay.

Authors:  R Tkacova; M Niroumand; G Lorenzi-Filho; T D Bradley
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

5.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

6.  Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.

Authors:  Ugo Corrà; Massimo Pistono; Alessandro Mezzani; Alberto Braghiroli; Andrea Giordano; Paola Lanfranchi; Enzo Bosimini; Marco Gnemmi; Pantaleo Giannuzzi
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

7.  RESP-24: a computer program for the investigation of 24-h breathing abnormalities in heart failure patients.

Authors:  R Maestri; G D Pinna; E Robbi; M Varanini; M Emdin; M Raciti; M T La Rovere
Journal:  Comput Methods Programs Biomed       Date:  2002-05       Impact factor: 5.428

8.  Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure.

Authors:  Ali Vazir; Peter C Hastings; Ioannis Papaioannou; Philip A Poole-Wilson; Martin R Cowie; Mary J Morrell; Anita K Simonds
Journal:  Respir Med       Date:  2008-03-17       Impact factor: 3.415

9.  The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers.

Authors:  Mary MacDonald; James Fang; Steven D Pittman; David P White; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

10.  Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure.

Authors:  Shahrokh Javaheri; Rakesh Shukla; Haoyue Zeigler; Laura Wexler
Journal:  J Am Coll Cardiol       Date:  2007-05-04       Impact factor: 24.094

View more
  10 in total

Review 1.  Neurobiology and neuropathophysiology of obstructive sleep apnea.

Authors:  Yanpeng Li; Sigrid C Veasey
Journal:  Neuromolecular Med       Date:  2011-12-15       Impact factor: 3.843

2.  The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failure.

Authors:  Neil R Ward; Vitor Roldao; Martin R Cowie; Stuart D Rosen; Theresa A McDonagh; Anita K Simonds; Mary J Morrell
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

3.  Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients?

Authors:  Gian Domenico Pinna; Elena Robbi; Fabio Pizza; Anna Eugenia Taurino; Caterina Pronzato; Maria Teresa La Rovere; Roberto Maestri
Journal:  Sleep Breath       Date:  2013-11-17       Impact factor: 2.816

Review 4.  Methodological strategies in using home sleep apnea testing in research and practice.

Authors:  Jennifer N Miller; Paula Schulz; Bunny Pozehl; Douglas Fiedler; Alissa Fial; Ann M Berger
Journal:  Sleep Breath       Date:  2017-11-14       Impact factor: 2.816

5.  Effects of sleep disordered breathing on functional capacity and quality of life in chronic kidney disease Egyptian patients.

Authors:  Eman S-D Khalil; Ehab I Mohamed; Gihane I Khalil; Samera M Sallam; Shaimaa S Mohamed; Salah S Naga; Mohamed N Mowafy
Journal:  Sleep Breath       Date:  2012-06-09       Impact factor: 2.816

6.  Is portable monitoring for diagnosing obstructive sleep apnea syndrome suitable in elderly population?

Authors:  Jéssica Fabia Polese; Rogerio Santos-Silva; Paula Martins de Oliveira Ferrari; Denis Eduardo Sartori; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2012-07-04       Impact factor: 2.816

7.  Association of sleep time in supine position with apnea-hypopnea index as evidenced by successive polysomnography.

Authors:  Gokhan Yalciner; Mehmet Ali Babademez; Fatih Gul
Journal:  Sleep Breath       Date:  2016-08-29       Impact factor: 2.816

8.  Variability and Misclassification of Sleep Apnea Severity Based on Multi-Night Testing.

Authors:  Naresh M Punjabi; Susheel Patil; Ciprian Crainiceanu; R Nisha Aurora
Journal:  Chest       Date:  2020-02-17       Impact factor: 9.410

Review 9.  Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring.

Authors:  Dominik Linz; Mathias Baumert; Lien Desteghe; Kadhim Kadhim; Kevin Vernooy; Jonathan M Kalman; Dobromir Dobrev; Michael Arzt; Manu Sastry; Harry J G M Crijns; Ulrich Schotten; Martin R Cowie; R Doug McEvoy; Hein Heidbuchel; Jeroen Hendriks; Prashanthan Sanders; Dennis H Lau
Journal:  Int J Cardiol Heart Vasc       Date:  2019-10-18

10.  Risk factors associated with the severity of obstructive sleep apnea syndrome among adults.

Authors:  Xiaobo Zhou; Qiao Lu; Shaoping Li; Zhongyin Pu; Fang Gao; Bo Zhou
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.